Skip to main content

ADVERTISEMENT

primary cytoreductive surgery

Research in Review
11/23/2016
JCP Editors
Primary cytoreductive surgery (PCS) is better than neoadjuvant chemotherapy (NACT) for overall survival in women aged 70 years or younger with advanced-stage epithelial ovarian cancer (EOC), according to a recent...
Primary cytoreductive surgery (PCS) is better than neoadjuvant chemotherapy (NACT) for overall survival in women aged 70 years or younger with advanced-stage epithelial ovarian cancer (EOC), according to a recent...
...
11/23/2016
Journal of Clinical Pathways